Press release
Oxytocic Pharmaceutical Market Is Likely to Experience a Tremendous Growth during 2020-2025| Analysis by Pfizer, Baxter Healthcare, Ferring
Oxytocic Pharmaceutical
Global Oxytocic Pharmaceutical Market Overview:
The report provides actionable insights to improve source-to-contract cycle performance in the Global Oxytocic Pharmaceutical Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
Oxytocic are the type of drugs used at the end of pregnancy, during labor pain and post-delivery which make to take a discerning action on the contraction of smooth musculature of the uterus. Oxytocic drugs are used is various field of obstetrics such as induction of labor, treatment of labor arrest, contraction stress test, management of labor and for the treatment of uterine atony and postpartum hemorrhage. The drug is also used to abort the fetus in case of miscarriage. For the anticipation of uterine atony, oxytocic drugs are given following C-section. Synthetic derivatives of oxytocin can induce antidiuretic activity due to nonappearance of vasopressin.
The report has been accumulated through meticulous primary and secondary research, which encompasses interviews, inspections, and observations of experienced analysts, as well as proven paid sources, news articles, annual reports, trade journals, and company body databases. The study also presents a qualitative and quantitative evaluation by analyzing the data collected from industry professionals and market participants across crucial factors in the industry's value chain. These segments are studied in detail for the market estimates and forecasts at regional and country level. This analysis is useful in understanding the growth areas and probable opportunities of the market.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/232022 .
Market Key Players
The global Oxytocic Pharmaceutical market is marked by some strong competition from the major players operating in this industry. Many merger and acquisition, joint venture and partnership agreement, product innovation, research and development and geographical extension are some of the key strategies adopted by this player to ensure long term sustenance in these market key participants in the global Oxytocic Pharmaceutical industry include, Fresenius Kaci, Biofutura, Baxter Healthcare, Pfizer, Ferring, Novartis…more
Segmentations
The Oxytocic Pharmaceutical market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
Product Type Segmentation : Natural Oxytocin, Synthetic Oxytocin Derivative
Industry Segmentation: Hospitals, Maternity Clinics
Regional Segmentation
North America (NA) – US & Rest of North America
Europe (EU) – UK, Germany, France & Rest of Europe
Asia Pacific (APAC) – China, Japan, India & Rest of APAC
Latin America (LA) – Brazil & Rest of Latin America
Middle East & Africa (MEA) – Middle East and Africa
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Oxytocic Pharmaceutical Report 2020” @ https://www.businessindustryreports.com/buy-now/232022/single .
Global Industry News:
PFIZER : October 08, 2020 PFIZER ANNOUNCES POSITIVE PHASE 3 TOP-LINE RESULTS FOR ONCE-WEEKLY INVESTIGATIONAL LONG-ACTING HUMAN GROWTH HORMONE TO TREAT CHILDREN WITH GROWTH HORMONE DEFICIENCY
Pfizer Inc.and OPKO Health Inc.announced today that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study evaluating somatrogon dosed once-weekly in children 3 to greater then 18 years of age with growth hormone deficiency (GHD), met its primary endpoint of improved treatment burden compared to GENOTROPIN® (somatropin) for injection administered once-daily.
Top-line results from the study demonstrated that treatment with somatrogon once-weekly improved the mean overall Life Interference total score after 12 weeks of treatment (8.63) compared to treatment with somatropin administered once-daily (24.13). The point estimate of the treatment difference was -15.49 (-19.71, -11.27 (95% CI); p greater then 0.0001) in favor of somatrogon at the nominal 0.05 level. In addition, key secondary endpoints showed an overall benefit in treatment experience with the somatrogon once-weekly dosing regimen compared to the somatropin once-daily dosing regimen.
“We’re encouraged by findings to date that demonstrate once-weekly somatrogon, if approved, has the potential to reduce lifestyle interference, support patient preference, and improve adherence as compared to a daily treatment,” said Brenda Cooperstone, MD, Chief Development Officer, Rare Disease, Pfizer Global Product Development. “Patients and their loved ones have endured the burden of daily growth hormone injections for nearly 40 years, and we are working to improve this current standard of care with a long-acting, weekly option for the growth hormone disorders community.”
No serious adverse events (SAEs) were reported during either of the treatment periods, and one participant discontinued use of somatrogon following a nonserious treatment-emergent adverse event (AE). The incidence of treatment-emergent AEs between the treatment arms were comparable and all AEs were mild to moderate in severity.
Key Points Covered :
This research study inspects the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-complexity information regarding the development, trends, and industry policies and guidelines implemented in each of the geographical regions. Further, the overall directing framework of the market has been thoroughly covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/232022 .
Major Points in Table of Contents:
Global Oxytocic Pharmaceutical Market Report 2020
1 Oxytocic Pharmaceutical Product Definition
2 Global Oxytocic Pharmaceutical Market Manufacturer Share and Market Overview
3 Manufacturer Oxytocic Pharmaceutical Business Introduction
4 Global Oxytocic Pharmaceutical Market Segmentation (Region Level)
5 Global Oxytocic Pharmaceutical Market Segmentation (Product Type Level)
6 Global Oxytocic Pharmaceutical Market Segmentation (Industry Level)
7 Global Oxytocic Pharmaceutical Market Segmentation (Channel Level)
8 Oxytocic Pharmaceutical Market Forecast 2020-2025
9 Oxytocic Pharmaceutical Segmentation Product Type
10 Oxytocic Pharmaceutical Segmentation Industry………………. Request free sample to get a complete Table of Content
About us
BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Media Contact
Business Industry Reports
Pune – India
sales@businessindustryreports.com
+19376349940
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oxytocic Pharmaceutical Market Is Likely to Experience a Tremendous Growth during 2020-2025| Analysis by Pfizer, Baxter Healthcare, Ferring here
News-ID: 2168839 • Views: …
More Releases from Business Industry Reports
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,…
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market:
This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities…
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market:
This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,…
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis:
The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast…
More Releases for Oxytocic
Oxytocic Pharmaceuticals Industry Surges as Maternal Healthcare Improves. Oxytoc …
In 2023 the Oxytocic Pharmaceuticals Market is expected to be worth US$ 114.58 million. The oxytocic pharmaceuticals industry is anticipated to develop at a CAGR of 7.8% from 2023 to 2033, reaching a value of US$ 242.83 million.
The expanding trend of giving birth in hospitals and the rise in cesarean operations significantly contribute to the expansion of oxytocic pharmaceuticals. In obstetrics, oxytocic medications serve multiple purposes, such as labor…
Global Oxytocic Medicine Market Research Report 2023-2029
Oxytocic medicines, also known as uterotonic agents, are medications used to induce or augment labor and to control postpartum bleeding. These medications work by stimulating uterine contractions, helping the uterus to contract and relax effectively during childbirth or after delivery. Oxytocic medicines are commonly used in obstetrics and are administered under the supervision of healthcare professionals.
Global Oxytocic Medicine Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis…
Oxytocic Pharmaceuticals Market
Oxytocic Pharmaceuticals Market Report
The global Oxytocic Pharmaceuticals market research report meticulously examines the company's present situation and potential future. The extensive primary and secondary research used to compile the report's contents yielded all pertinent market information. The research provides in-depth information on the market size, share, production capability, demand, and growth of the industry over the course of the projection period. For market operators preparing for approaching pandemics, the most…
Global Oxytocic Pharmaceutical Market
The oxytocic pharmaceutical market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account by 2027 growing at a CAGR of 9.4% in the above-mentioned forecast period
Global Oxytocic Pharmaceutical Market Definition
There are certain conditions such as pre-eclampsia where pregnancy is dangerous for the mother, or when women are uncomfortable, sore and tired. In such cases, labour…
Upcoming Trends in Oxytocic Pharmaceuticals Market
Global Oxytocic Pharmaceuticals Market: Overview
Dubbed the “love hormone,” oxytocin is a female reproductive hormone, produced in the hypothalamus and released into bloodstream during childbirth. This hormone induces labor and milk production in a lactating mother. Oxytocic drugs can be used as uterotonic for induced labor and to reduce the chances of hemorrhage post C-section. Besides this, oxytocic drugs are also administered in conditions such as post-mature birth; uterine atony;…
Oxytocic Pharmaceuticals Market worth US$ 157.6 Mn by 2026
Though synthetic oxytocin is chemically equivalent to naturally-occurring oxytocin, their pharmaceutical functions for aiding women in labour are quite distinctive. Medical professionals from around the world will continue to recommend synthetic-based oxytocic pharmaceuticals over natural since oxytocic pharmaceuticals originating from synthetic sources can boost the momentum of decelerated labour by IV administration. More than 90% of the global market revenues for oxytocic pharmaceuticals will be harvested from the sales of…
